SCHEMBL1818967

SCHEMBL1818967

COc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc(O)cc2)CCO3)ccc1C#N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CPT1A P50416 3/20 0.39
▸ PGR P06401 1/20 0.39
▸ AR P10275 1/20 0.39
▸ CPT1B Q92523 2/20 0.38
▸ CPT2 P23786 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ NR1H3 Q13133 2/20 0.38
▸ RORC P51449 1/20 0.38
▸ NR1H2 P55055 1/20 0.38
▸ PKM P14618 4/20 0.37
▸ USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818577 0.91 NPC1 (0.58) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1818007 0.91 CYP2C9 (0.56) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1819920 0.91 NPC1 (0.47) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1816318 0.91 NPC1 (0.47) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1819412 0.89 NPC1 (0.45) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1818733 0.89 CYP2C9 (0.47) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1820258 0.88 NPC1 (0.45) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1817694 0.87 POLB (0.46) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1819918 0.87 NPC1 (0.48) CYP2C9NPC1CYP3A4CYP2D6KMT2A
SCHEMBL1816628 0.85 POLB (0.45) CYP2C9NPC1CYP3A4CYP2D6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback